Literature DB >> 96010

Further studies of immunoglobulin synthesis by guinea pig leukaemic lymphocytes.

D W Hough, J C Chapple, F K Stevenson, G T Stevenson.   

Abstract

The L2C leukaemia is a B-lymphocytic neoplasm of strain 2 guinea-pigs, maintained by passaging in vivo. It synthesizes mu and lambda immunoglobulin chains. These combines to form monomeric (7S) IgM molecules which are inserted into the plasma membranes. From here they are shed as monomeric IgM and as a species of higher molecular weight which has not been further defined. The synthesis of lambda chain is in excess of that required for the IgM molecule, the surplus being exported directly from the cell without any intervening phase in the plasma membrane. Quantitative estimates of synthetic rates and pool sizes for these immunoglobulin species are presented.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 96010      PMCID: PMC1457203     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  22 in total

1.  Recovery of immunoglobulin removed from lymphocytic surfaces by proteolysis.

Authors:  R P Eady; D W Hough; P J Kilshaw; G T Stevenson
Journal:  Immunology       Date:  1974-03       Impact factor: 7.397

2.  Some effects on leukaemic B lymphocytes of antibodies to defined regions of their surface immunoglobulin.

Authors:  F K Stevenson; E V Elliott; G T Stevenson
Journal:  Immunology       Date:  1977-04       Impact factor: 7.397

3.  Urinary light chain excretion in leukaemia and lymphoma.

Authors:  F D Lindström; R C Williams; A Theologides
Journal:  Clin Exp Immunol       Date:  1969-07       Impact factor: 4.330

4.  A gamma Bence-Jones protein in guinea pigs.

Authors:  F K Stevenson; L E Mole; C M Raymont; G T Stevenson
Journal:  Biochem J       Date:  1975-12       Impact factor: 3.857

5.  Antibody to a molecularly-defined antigen confined to a tumour cell surface.

Authors:  G T Stevenson; F K Stevenson
Journal:  Nature       Date:  1975-04-24       Impact factor: 49.962

6.  Mitogen activation of human chronic lymphatic leukemia cells. I. Synthesis and secretion of immunoglobulin.

Authors:  V C Maino; J T Kurnick; R T Kubo; H M Grey
Journal:  J Immunol       Date:  1977-03       Impact factor: 5.422

7.  Mutant lines of guinea pig L2C leukemia. I. Deletion of Ia alloantigens is associated with a loss in immunogenicity of tumor-associated transplantation antigens.

Authors:  G Forni; E M Shevach; I Green
Journal:  J Exp Med       Date:  1976-05-01       Impact factor: 14.307

8.  NATURALLY OCCURRING HUMAN ANTIBODY REACTING WITH BENCE JONES PROTEINS.

Authors:  W V EPSTEIN; D GROSS
Journal:  J Exp Med       Date:  1964-11-01       Impact factor: 14.307

9.  Occurrence of surface IgM, IgD, and free light chains of human lymphocytes.

Authors:  S M Fu; R J Winchester; H G Kunkel
Journal:  J Exp Med       Date:  1974-02-01       Impact factor: 14.307

10.  Cell surface immunoglobulin. II. Isolation and characterization of immunoglobulin from mouse splenic lymphocytes.

Authors:  E S Vitetta; S Baur; J W Uhr
Journal:  J Exp Med       Date:  1971-07-01       Impact factor: 14.307

View more
  7 in total

1.  Preferential expression of IgG1 antibodies specific for L2C leukaemia IgM idiotypic determinants in tumour-protected strain 2 guinea-pigs.

Authors:  M J Ricardo; D T Grimm
Journal:  Immunology       Date:  1983-04       Impact factor: 7.397

Review 2.  Treatment of lymphoid tumors with anti-idiotype antibodies.

Authors:  G T Stevenson; F K Stevenson
Journal:  Springer Semin Immunopathol       Date:  1983

3.  Antigenic modulation of lymphocytic surface immunoglobulin yielding resistance to complement-mediated lysis. I. Characterization with syngeneic and xenogeneic complements.

Authors:  J Gordon; D S Robinson; G T Stevenson
Journal:  Immunology       Date:  1981-01       Impact factor: 7.397

4.  Immunoglobulin produced by guinea-pig leukaemic B lymphocytes: its source and use as a monitor of tumour load.

Authors:  F K Stevenson; D Morris; G T Stevenson
Journal:  Immunology       Date:  1980-10       Impact factor: 7.397

5.  Emergence of immunoglobulin variants following treatment of a B cell leukemia with an immunotoxin composed of antiidiotypic antibody and saporin.

Authors:  M J Glennie; H M McBride; F Stirpe; P E Thorpe; A T Worth; G T Stevenson
Journal:  J Exp Med       Date:  1987-07-01       Impact factor: 14.307

6.  Antibody-induced changes in levels of cyclic adenosine monophosphate in leukaemic lymphocytes.

Authors:  M Virji; G T Stevenson
Journal:  Br J Cancer       Date:  1979-04       Impact factor: 7.640

7.  Consumption of monoclonal anti-idiotypic antibody by neoplastic B lymphocytes: a guide for immunotherapy.

Authors:  F K Stevenson; M J Glennie; D M Johnston; A L Tutt; G T Stevenson
Journal:  Br J Cancer       Date:  1984-09       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.